Clinical trial

A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State

NCT00744679

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE4

Study timeline

Study start (unknown)2008-11-01Date precision: month

Registry last updated2015-02-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

NatalizumabDRUG · verified · RxNorm: natalizumab

Sponsors & collaborators

Biogenlead sponsor

Elan Pharmaceuticalscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00744679 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.